Cargando…
Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
OBJECTIVE: Brain parenchymal involvement in Behçet's disease (BD) (neuro-Behçet's disease, NB) can be classified into acute type (ANB) and chronic progressive type (CPNB) based on differences in the clinical course and responses to corticosteroid treatment. The present study developed evid...
Autores principales: | Hirohata, Shunsei, Kikuchi, Hirotoshi, Sawada, Tetsuji, Okada, Masato, Takeno, Mitsuhiro, Kuwana, Masataka, Kawachi, Izumi, Mochizuki, Hideki, Kusunoki, Susumu, Ishigatsubo, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644487/ https://www.ncbi.nlm.nih.gov/pubmed/32611961 http://dx.doi.org/10.2169/internalmedicine.4705-20 |
Ejemplares similares
-
Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysis
por: Hirohata, Shunsei, et al.
Publicado: (2011) -
Behçet's disease
por: Hirohata, Shunsei, et al.
Publicado: (2003) -
Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015) -
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017) -
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study
por: Hibi, Toshifumi, et al.
Publicado: (2016)